SCHEMBL17447441

SCHEMBL17447441

O=C(I)n1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15846673 0.79 FAAH (0.45)
SCHEMBL618874 0.79 ALDH1A1 (0.43)
SCHEMBL1325 0.79 FAAH (0.45)
Hydrogen Sulfide SCHEMBL10814521 0.77 FAAH (0.44)
Phosphine SCHEMBL31680518 0.77 FAAH (0.44)
SCHEMBL6558961 0.77
SCHEMBL2194853 0.77 FAAH (0.44)
SCHEMBL173415 0.77
SCHEMBL10814524 0.77 FAAH (0.44)
Hydrochloric Acid SCHEMBL6226784 0.77 FAAH (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250181-A1 MODIFIED CHECKPOINT INHIBITORS AND USES THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2023-08-10 US disclosed
US-20230201364-A1 ANTIBODY CONJUGATES AND MANUFACTURE THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2023-06-29 US disclosed
WO-2016008582-A1 SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES Grünenthal GmbH (DE) 2016-01-21 WO disclosed